← Open Payments lookup

CHARLES MIKULKA: Open Payments

NPI 1801676333 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$601 in 22 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $309 · 2025 $601

Food & beverage: $601
CompanyPaymentsAmount
Madrigal Pharmaceuticals3$176
PFIZER INC.5$90
GENZYME CORPORATION3$82
Janssen Biotech, Inc.2$62
Ardelyx, Inc.2$57
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$42
ABBVIE INC.2$40
Lilly USA, LLC2$32
Novo Nordisk Inc1$20

Products named: REZDIFFRA, VELSIPITY, DUPIXENT, TREMFYA, IBSRELA, XIFAXAN, OMVOH, RINVOQ.

Industry payments across DE — which companies pay providers there.